O'Shaughnessy Asset Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
JFG
O'Shaughnessy Asset Management's XBI Position: Q2 2026 in Review
O'Shaughnessy Asset Management reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 3.2% in Q2 2026, selling an estimated $8.79K and leaving 1,990 shares worth $315K. The position accounts for ﹤0.01% of the portfolio, ranked #1803.
O'Shaughnessy Asset Management first reported a position in XBI in Q3 2020 and has held it in 13 quarters since. 936 funds tracked by Wall St. Rank hold XBI as of Q2 2026.
- O'Shaughnessy Asset Management held 1,990 shares of State Street SPDR S&P Biotech ETF worth $315K as of Q2 2026.
- O'Shaughnessy Asset Management sold 65 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $8.79K.
- State Street SPDR S&P Biotech ETF made up ﹤0.01% of O'Shaughnessy Asset Management's portfolio in Q2 2026, its #1803 holding.
- O'Shaughnessy Asset Management first reported a position in State Street SPDR S&P Biotech ETF in Q3 2020 and has held it in 13 quarters since.
- 936 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.
Based on O'Shaughnessy Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.